Eric B. Harstad
Impact in
-
- Toxic Organic Pollutants Impact
- Heavy Metal Exposure and Toxicity
- Effects and risks of endocrine disrupting chemicals
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 2
- HER2/EGFR in Cancer Research 2
-
- Phytochemical compounds biological activities 2
- Co-authors
- Curtis D. Klaassen (3 shared papers)Christopher A. Bradfield (2 shared papers)Edward Glover (1 shared paper)Maureen K. Bunger (1 shared paper)Jacqueline A. Walisser (1 shared paper)Melissa M. Schutten (3 shared papers)S.J. Enna (1 shared paper)Kenneth E. McCarson (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Toxicological Sciences (2 papers)Clinical Cancer Research (1 paper)Journal of Medicinal Chemistry (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Eric B. Harstad
20 papers receiving 633 citations
Peers
Comparison fields: 5 of 92
- Health, Toxicology and Mutagenesis 150
- Oncology 165
- Pharmacology 46
- Cancer Research 67
- Pathology and Forensic Medicine 63
Countries citing papers authored by Eric B. Harstad
This map shows the geographic impact of Eric B. Harstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric B. Harstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric B. Harstad more than expected).
Fields of papers citing papers by Eric B. Harstad
This network shows the impact of papers produced by Eric B. Harstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric B. Harstad. The network helps show where Eric B. Harstad may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric B. Harstad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 102 | |
| 2 | 2015 | 70 | |
| 3 | 2015 | 66 | |
| 4 | 2013 | 57 | |
| 5 | 2006 | 49 | |
| 6 | 2012 | 49 | |
| 7 | 2002 | 43 | |
| 8 | 2002 | 31 | |
| 9 | 2002 | 29 | |
| 10 | 1998 | 28 | |
| 11 | 2002 | 26 | |
| 12 | 2012 | 22 | |
| 13 | 2017 | 19 | |
| 14 | 2013 | 15 | |
| 15 | 2016 | 14 | |
| 16 | 2024 | 13 | |
| 17 | 2022 | 11 | |
| 18 | 2013 | 9 | |
| 19 | 2022 | 7 | |
| 20 | 2011 | 1 |
About Eric B. Harstad
Eric B. Harstad is a scholar working on Oncology, Molecular Biology, Health, Toxicology and Mutagenesis, Nutrition and Dietetics and Pharmacology, having authored 21 papers that have together received 661 indexed citations. Recurring topics across this work include Trace Elements in Health (4 papers), Heavy Metal Exposure and Toxicity (4 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Phytochemical compounds biological activities (2 papers), Drug Transport and Resistance Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Synthesis and biological activity (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (150 citations), Oncology (165 citations), Pharmacology (46 citations), Cancer Research (67 citations) and Pathology and Forensic Medicine (63 citations). Eric B. Harstad has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Curtis D. Klaassen, Christopher A. Bradfield, Edward Glover, Maureen K. Bunger, Jacqueline A. Walisser, Melissa M. Schutten, S.J. Enna, Kenneth E. McCarson, Dolores Diaz and Jason Boggs. Their work appears in journals such as Toxicology and Applied Pharmacology, Toxicological Sciences, Clinical Cancer Research, Journal of Medicinal Chemistry and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.